Cannabis Business Aims to Reproduce Rare Cannabinoids Using DNA
The biotech that is boston-based Gingko Bioworks Inc. recently announced a major partnership with Canadian cannabis company Cronos Group Inc. to function on what could possibly be a groundbreaking and innovation that is potentially epoch-shifting in cannabis manufacturing. Taking a typical page straight away from Jurassic Park, Gingko would like to make use of plant DNA to genetically (re)produce cannabinoids directly, without growing the cannabis plants that obviously create them.
